Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
2.670
+0.100 (3.89%)
At close: Nov 20, 2024, 4:00 PM
2.748
+0.078 (2.91%)
After-hours: Nov 20, 2024, 6:47 PM EST
Agenus Employees
Agenus had 389 employees as of December 31, 2023. The number of employees decreased by 144 or -27.02% compared to the previous year.
Employees
389
Change (1Y)
-144
Growth (1Y)
-27.02%
Revenue / Employee
$412,409
Profits / Employee
-$585,751
Market Cap
62.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Xtant Medical Holdings | 215 |
Mural Oncology | 117 |
VolitionRx | 110 |
DBV Technologies | 105 |
X4 Pharmaceuticals | 93 |
Boundless Bio | 72 |
Immuneering | 68 |
IO Biotech | 68 |
AGEN News
- 8 days ago - Agenus Inc. (AGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development - Business Wire
- 13 days ago - Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024 - Business Wire
- 15 days ago - Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update - Business Wire
- 16 days ago - November 5 Deadline: Agenus Inc Is Being Sued For Defrauding The Public And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 17 days ago - The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Agenus Inc. - Accesswire
- 18 days ago - Agenus Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 20 days ago - The Schall Law Firm Encourages Investors To Take Part In A Securities Fraud Case Against Agenus Inc. - Accesswire